Accumulation of amino-polyvinyl alcohol-coated superparamagnetic iron oxide nanoparticles in bone marrow: implications for local stromal cells

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Corot C, Robert P, Idee JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 58(14), 1471–1504 (2006).
  Medline CASGoogle Scholar
• 2 Gossuin Y, Gillis P, Hocq A, Vuong QL, Roch A. Magnetic resonance relaxation properties of superparamagnetic particles. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1(3), 299–310 (2009).
  Medline CASGoogle Scholar
• 3 Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18), 3995–4021 (2005).
  Medline CASGoogle Scholar
• 4 Li M, Al-Jamal KT, Kostarelos K, Reineke J. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano 4(11), 6303–6317 (2010).• Systematic review on the effect of physiochemical properties on the biodistribution of nanoparticles.
  Medline CASGoogle Scholar
• 5 Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11(11), 2319–2331 (2001).
  Medline CASGoogle Scholar
• 6 Weissleder R, Stark DD, Engelstad BL et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am. J. Roentgenol. 152(1), 167–173 (1989).
  Medline CASGoogle Scholar
• 7 Metz S, Lohr S, Settles M et al. Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas. Eur. Radiol. 16(3), 598–607 (2006).
  MedlineGoogle Scholar
• 8 Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175(2), 494–498 (1990).
  Medline CASGoogle Scholar
• 9 Daldrup-Link HE, Rummeny EJ, Ihssen B, Kienast J, Link TM. Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow. Eur. Radiol. 12(6), 1557–1566 (2002).
  MedlineGoogle Scholar
• 10 Simon GH, Raatschen HJ, Wendland MF et al. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research. Acad. Radiol. 12(9), 1190–1197 (2005).•• Different superparamagnetic iron oxide nanoparticles (SPIONs) are evaluated for contrast enhancement in bone marrow. Effect on local cells is not discussed.
  MedlineGoogle Scholar
• 11 Panahifar A, Mahmoudi M, Doschak MR. Synthesis and in vitro evaluation of bone-seeking superparamagnetic iron oxide nanoparticles as contrast agents for imaging bone metabolic activity. ACS Appl. Mater. Interfaces 5(11), 5219–5226 (2013).• An interesting approach for targeting bone marrow by using bisphosphonate as a surface functionalization on SPIONs.
  Medline CASGoogle Scholar
• 12 Pareta RA, Taylor E, Webster TJ. Increased osteoblast density in the presence of novel calcium phosphate coated magnetic nanoparticles. Nanotechnology 19(26), 265101 (2008).
  MedlineGoogle Scholar
• 13 Petri-Fink A, Hofmann H. Superparamagnetic iron oxide nanoparticles (SPIONs): from synthesis to in vivo studies – a summary of the synthesis, characterization, in vitro and in vivo investigations of SPIONs with particular focus on surface and colloidal properties. IEEE Transact. Nanobiosci. 6(4), 289–297 (2007).
  MedlineGoogle Scholar
• 14 Schulze F, Dienelt A, Geissler S et al. Amino-polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles are suitable for monitoring of human mesenchymal stromal cells in vivo. Small 10(21), 4340–4351 (2014).• Evaluates the same amino-polyvinyl alcohol-coated SPIONs used in the current study for cell labeling in vitro.
  Medline CASGoogle Scholar
• 15 Gramoun A, Crowe LA, Maurizi L et al. Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages. Arthritis Res. Ther. 16(3), R131 (2014).
  MedlineGoogle Scholar
• 16 Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276(5309), 71–74 (1997).
  Medline CASGoogle Scholar
• 17 Prockop DJ, Kota DJ, Bazhanov N, Reger RL. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J. Cell. Mol. Med. 14(9), 2190–2199 (2010).
  MedlineGoogle Scholar
• 18 Park D, Spencer JA, Koh BI et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 10(3), 259–272 (2012).
  Medline CASGoogle Scholar
• 19 Ode A, Kopf J, Kurtz A et al. CD73 and CD29 concurrently mediate the mechanically induced decrease of migratory capacity of mesenchymal stromal cells. Eur. Cells Mater. 22, 26–42 (2011).
  Medline CASGoogle Scholar
• 20 Jones E, Yang X. Mesenchymal stem cells and bone regeneration: current status. Injury 42(6), 562–568 (2011).
  MedlineGoogle Scholar
• 21 Fischer HC, Chan WC. Nanotoxicity: the growing need for in vivo study. Curr. Opin. Biotechnol. 18(6), 565–571 (2007).
  Medline CASGoogle Scholar
• 22 Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7(4), 292–304 (2007).
  Medline CASGoogle Scholar
• 23 Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99(10), 3838–3843 (2002).
  Medline CASGoogle Scholar
• 24 Jiang XX, Zhang Y, Liu B et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105(10), 4120–4126 (2005).
  Medline CASGoogle Scholar
• 25 Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 110(10), 3499–3506 (2007).
  Medline CASGoogle Scholar
• 26 Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107(4), 1484–1490 (2006).
  Medline CASGoogle Scholar
• 27 Liu Y, Wang L, Kikuiri T et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha. Nat. Med. 17(12), 1594–1601 (2011).
  Medline CASGoogle Scholar
• 28 Reinke S, Geissler S, Taylor WR et al. Terminally differentiated CD8(⁺) T cells negatively affect bone regeneration in humans. Sci. Transl. Med. 5(177), 177ra136 (2013).
  Google Scholar
• 29 Chastellain M, Petri A, Hofmann H. Particle size investigations of a multistep synthesis of PVA coated superparamagnetic nanoparticles. J. Colloid Interface Sci. 278(2), 353–360 (2004).
  Medline CASGoogle Scholar
• 30 Massart R, Dubois E, Cabuil V, Hasmonay E. Preparation and properties of monodisperse magnetic fluids. J. Magn. Magn. Mater. 149(1–2), 1–5 (1995).
  CASGoogle Scholar
• 31 Petri-Fink A, Chastellain M, Juillerat-Jeanneret L, Ferrari A, Hofmann H. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 26(15), 2685–2694 (2005).
  Medline CASGoogle Scholar
• 32 Schulze K, Koch A, Schopf B et al. Intraarticular application of superparamagnetic nanoparticles and their uptake by synovial membrane – an experimental study in sheep. J. Magn. Magn. Mater. 293(1), 419–432 (2005).
  CASGoogle Scholar
• 33 Dobson KR, Reading L, Haberey M, Marine X, Scutt A. Centrifugal isolation of bone marrow from bone: an improved method for the recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae. Calci. Tissue Int. 65(5), 411–413 (1999).
  Medline CASGoogle Scholar
• 34 Kim YH, Yoon DS, Kim HO, Lee JW. Characterization of different subpopulations from bone marrow-derived mesenchymal stromal cells by alkaline phosphatase expression. Stem Cells Dev. 21(16), 2958–2968 (2012).
  Medline CASGoogle Scholar
• 35 O'Brien J, Wilson I, Orton T, Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267(17), 5421–5426 (2000).
  MedlineGoogle Scholar
• 36 Gonzalez RJ, Tarloff JB. Evaluation of hepatic subcellular fractions for Alamar Blue and MTT reductase activity. Toxicol. In Vitro 15(3), 257–259 (2001).
  Medline CASGoogle Scholar
• 37 Kitamura S, Sugihara K, Ohta S. Drug-metabolizing ability of molybdenum hydroxylases. Drug Metabol. Pharmacokinet. 21(2), 83–98 (2006).
  Medline CASGoogle Scholar
• 38 Battelli MG, Bolognesi A, Polito L. Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme. Biochim. Biophys. Acta 1842(9), 1502–1517 (2014).
  Medline CASGoogle Scholar
• 39 Arora S, Rajwade JM, Paknikar KM. Nanotoxicology and in vitro studies: the need of the hour. Toxicol. Appl. Pharmacol. 258(2), 151–165 (2012).•• The gap between applied doses in vitro and real-life expostion in vivo is discussed.
  Medline CASGoogle Scholar
• 40 Oberdorster G. Nanotoxicology: in vitro–in vivo dosimetry. Environ. Health Perspect. 120(1), A13; author reply A13 (2012).• The in vivo dosage for lung cells is determined and dose–response relationships between in vivo and in vitro experiments are compared.
  MedlineGoogle Scholar
• 41 Teeguarden JG, Mikheev VB, Minard KR et al. Comparative iron oxide nanoparticle cellular dosimetry and response in mice by the inhalation and liquid cell culture exposure routes. Part. Fibre Toxicol. 11(1), 46 (2014).
  MedlineGoogle Scholar
• 42 Khanbeigi RA, Kumar A, Sadouki F et al. The delivered dose: applying particokinetics to in vitro investigations of nanoparticle internalization by macrophages. J. Control. Release 162(2), 259–266 (2012).•• An introduction to partikokinetics and the siginificance of employing proper dosimetry for in vitro experiments.
  MedlineGoogle Scholar
• 43 Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 95(2), 300–312 (2007).
  Medline CASGoogle Scholar
• 44 Burke WT, Harris C. Total cell counts of the bone marrow of normal albino rats from 1 to 50 weeks of age. Blood 14(4), 409–414 (1959).
  Medline CASGoogle Scholar
• 45 Landazuri N, Tong S, Suo J et al. Magnetic targeting of human mesenchymal stem cells with internalized superparamagnetic iron oxide nanoparticles. Small 9(23), 4017–4026 (2013).
  Medline CASGoogle Scholar
• 46 Shi Z, Neoh KG, Kang ET et al. (Carboxymethyl)chitosan-modified superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of stem cells. ACS Appl. Mater. Interfaces 1(2), 328–335 (2009).
  Medline CASGoogle Scholar
• 47 Wang L, Neoh KG, Kang ET, Shuter B, Wang SC. Biodegradable magnetic-fluorescent magnetite/poly(dl-lactic acid-co-alpha, beta-malic acid) composite nanoparticles for stem cell labeling. Biomaterials 31(13), 3502–3511 (2010).
  Medline CASGoogle Scholar
• 48 Lesniak A, Fenaroli F, Monopoli MP, Aberg C, Dawson KA, Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6(7), 5845–5857 (2012).
  Medline CASGoogle Scholar
• 49 Mortensen NP, Hurst GB, Wang W, Foster CM, Nallathamby PD, Retterer ST. Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. Nanoscale 5(14), 6372–6380 (2013).
  Medline CASGoogle Scholar
• 50 Kasper J, Hermanns MI, Bantz C et al. Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: comparison with conventional monocultures. Part. Fibre Toxicol. 8(1), 6 (2011).
  Medline CASGoogle Scholar
• 51 Wottrich R, Diabate S, Krug HF. Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture. Int. J. Hyg. Environ. Health 207(4), 353–361 (2004).
  Medline CASGoogle Scholar
• 52 Zhang E, Kircher MF, Koch M, Eliasson L, Goldberg SN, Renstrom E. Dynamic magnetic fields remote-control apoptosis via nanoparticle rotation. ACS Nano 8(4), 3192–3201 (2014).•• The use of a novel dynamic magnetic field generator for control over SPIONs’ motion is described.
  Medline CASGoogle Scholar
• 53 Krug HF, Wick P. Nanotoxicology: an interdisciplinary challenge. Angew. Chem. Int. Ed. Engl. 50(6), 1260–1278 (2011).
  Medline CASGoogle Scholar
• 54 Schrurs F, Lison D. Focusing the research efforts. Nat. Nanotechnol. 7(9), 546–548 (2012).
  Medline CASGoogle Scholar
• 55 Doorn PF, Campbell PA, Worrall J, Benya PD, Mckellop HA, Amstutz HC. Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J. Biomed. Mater. Res. 42(1), 103–111 (1998).
  Medline CASGoogle Scholar